Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ashfield is a global leader in commercialization services for the pharmaceutical and life sciences industries. The company provides a diverse suite of services including medical communications, contract sales forces, patient engagement programs, and strategic consulting. Originally a division of UDG Healthcare, Ashfield was acquired by Clayton, Dubilier & Rice in 2021 and subsequently merged with Huntsworth to form Inizio. The organization supports biopharma clients across the entire product lifecycle, helping to communicate the value of medicines and improve patient outcomes through integrated healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ashfield Commercial & Medical Services.